| Use of Serogroup B Meningococcal Vaccines in Persons Aged≥ 10 Years at Increased Risk for Serogroup B Meningococcal Disease: Recommendations of the Advisory Committee on … T Folaranmi, L Rubin, S Martin, M Patel, J MacNeil MMWR 64 (22), 608-612, 2015 | 254 | 2015 |
| Big data in global health: improving health in low-and middle-income countries R Wyber, S Vaillancourt, W Perry, P Mannava, T Folaranmi, LA Celid WHO Bulletin, 2015 | 235 | 2015 |
| Use of serogroup B meningococcal vaccines in adolescents and young adults: recommendations of the Advisory Committee on Immunization Practices, 2015 JR MacNeil, L Rubin, T Folaranmi, IR Ortega-Sanchez, M Patel, ... Morbidity and Mortality Weekly Report 64 (41), 1171-1176, 2015 | 231 | 2015 |
| Increased risk for meningococcal disease among men who have sex with men in the United States, 2012–2015 TA Folaranmi, CB Kretz, H Kamiya, JR MacNeil, MJ Whaley, A Blain, ... Clinical Infectious Diseases 65 (5), 756-763, 2017 | 70 | 2017 |
| Nigeria's new government and public financing for universal health coverage A Awosusi, T Folaranmi, R Yates Lancet Global Health 3 (9), e514-e515, 2015 | 64 | 2015 |
| mHealth in Africa: challenges and opportunities T Folaranmi Perspectives in public health 134 (1), 14, 2014 | 49 | 2014 |
| Efficacy and effectiveness of a 23-valent polysaccharide vaccine against invasive and noninvasive pneumococcal disease and related outcomes: a review of available evidence MS Niederman, T Folaranmi, UK Buchwald, L Musey, AW Cripps, ... Expert Review of Vaccines 20 (3), 243-256, 2021 | 40 | 2021 |
| Centers for Disease Control (CDC) Use of serogroup B meningococcal vaccines in persons aged≥ 10 years at increased risk for serogroup B meningococcal disease: recommendations … T Folaranmi, L Rubin, SW Martin, M Patel, JR MacNeil MMWR Morb Mortal Wkly Rep 64 (22), 608-612, 2015 | 22 | 2015 |
| Food insecurity and malnutrition in Africa: current trends, causes and consequences T Folaranmi Consultancy Africa Intelligence 5, 14, 2012 | 21 | 2012 |
| Sequential administration of Prevnar 13™ and PNEUMOVAX™ 23 in healthy participants 50 years of age and older UK Buchwald, CP Andrews, J Ervin, JT Peterson, GM Tamms, D Krupa, ... Human Vaccines & Immunotherapeutics 17 (8), 2678-2690, 2021 | 14 | 2021 |
| Systematic review and meta-analysis of pertussis epidemiology in Latin America and the Caribbean: 1980–2015 T Folaranmi, V Pinell-McNamara, M Griffith, Y Hao, F Coronado, ... Revista Panamericana de Salud Pública 41, e102, 2018 | 14 | 2018 |
| Immunogenicity following revaccination or sequential vaccination with 23-valent pneumococcal polysaccharide vaccine (PPSV23) in older adults and those at increased risk of … AW Cripps, T Folaranmi, KD Johnson, L Musey, MS Niederman, ... Expert Review of Vaccines 20 (3), 257-267, 2021 | 10 | 2021 |
| A Japanese nationwide survey of 23-valent pneumococcal capsular polysaccharide vaccine (PPSV23) coverage among patients with chronic medical condition aged 50 and older K Kawakami, A Nakamura, A Wakana, TA Folaranmi, T Iino Human Vaccines & Immunotherapeutics 16 (7), 1521-1528, 2020 | 7 | 2020 |
| Centers for disease C T Folaranmi, L Rubin, SW Martin, M Patel, JR MacNeil Use of serogroup B meningococcal vaccines in persons aged 10, 0 | 5 | |
| A Japanese nationwide survey of 23-valent pneumococcal capsular polysaccharide vaccine (PPSV23) revaccination coverage rate among elderly adults aged 65 and older and physician … A Nakamura, K Kawakami, A Wakana, TA Folaranmi, T Iino Human Vaccines & Immunotherapeutics 16 (9), 2292-2299, 2020 | 4 | 2020 |
| Zika virus in Africa: Revitalising the discourse of health systems O Omole, T Folaranmi Perspectives in Public Health 136 (6), 333, 2016 | 2 | 2016 |
| The Japanese 23-valent pneumococcal polysaccharide vaccine randomized clinical trial: Further reflections on the design and results YA Cui, T Folaranmi, UK Buchwald Vaccine 39 (4), 641-643, 2021 | | 2021 |
| Response to Shami et al.‘Evaluating the cost-effectiveness of a sequential pneumococcal vaccination compared to single dose vaccination strategy for adults in Hong Kong’(Hum … UK Buchwald, T Folaranmi, T Weiss Human Vaccines & Immunotherapeutics 17 (1), 173-175, 2021 | | 2021 |
| Meningococcal disease among men who have sex with men–United States, January 2012-June 2015 TA Folaranmi | | 2016 |
| Grading of Recommendations, Assessment, Development, and Evaluation (GRADE): evidence for use of MenB Vaccines in adolescents and Young adults (including college students) TA Folaranmi | | 2015 |
